🔎Don't sleep on obesity innovation.

Oral GLP-1 is now available. But drug development won't stop there. RNA-based weight loss drugs are the next frontier. They promise higher efficacy with better muscle retention.

TLDR Summary

• GLP-1 drugs are first and foremost appetite suppressants. They slow down the digestion process. The patient then voluntarily eats less and the resulting caloric deficit burns excess fat. That’s why they work for weight loss.

• Because they are so powerful and because the addressable market is so large, the pace of innovation in this space remai…